|
|
Analysis of the situation and research hotspots of atherosclerosis projects funded by the National Natural Science Foundation of China from 2015 to 2019 |
ZHANG Yunnan1,2 ZHANG Yi1,2 WANG Yifan1,2 HAN Jialun1,2 LIN Baidi1,2 YAN Jialin1,2 SHI Xiujin1 LIN Yang1,2▲ |
1.Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China;
2.School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China |
|
|
Abstract Objective To analyze the arteriosclerosis-related projects funded by the National Natural Science Foundation of China from 2015 to 2019, to discuss current research hotspots in this field, and to provide references for subsequent research on atherosclerosis. Methods The atherosclerosis-related projects approved from 2015 to 2019 were counted, and the project year, type, and subject distribution were analyzed, while CiteSpace software for keyword visualization analysis was applied to explore the current funding hotspots of the National Natural Science Foundation of China in the field of atherosclerosis. Results In the past five years, the total number of atherosclerosis-related projects has been 662 items, and the number of projects each year has been relatively stable. Among them, the medical science department has 612 items (92.4%), which account for the highest proportion, and the establishment of the project showed the phenomenon of multi-disciplinary collaboration. The regional distribution of funded projects was uneven, and the projects were concentrated in Beijing, Shanghai, Guangdong and other regions. Keyword co-occurrence results showed that macrophages, inflammation, and endothelial cells were the top three keywords with frequency. Keyword clustering results showed that endothelial cells, macrophages, and microRNA were the top three research clusters. Conclusion The National Natural Science Foundation of China is an important national support for basic research. Researchers should grasp research hotspots, multi-disciplinary collaboration, and multi-technology joint application to promote deeper exploration of atherosclerosis research.
|
|
|
|
|
[1] Lu HS,Schmidt AM,Hegele RA,et al. Annual Report on Sex in Preclinical Studies:Arteriosclerosis,Thrombosis,and Vascular Biology Publications in 2018 [J]. Arterioscler Thromb Vasc Biol,2020,40(1):e1-e9.
[2] Tibaut M,Petrovic D. Oxidative Stress Genes,Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus [J]. Cardiovasc Hematol Agents Med Chem,2016,14(1):23-38.
[3] 张世田,唐汉庆,黄岑汉,等.氧化应激、炎症与冠状动脉粥样硬化关系的研究进展[J].右江医学,2017,45(2):235-239.
[4] 王秀华,杨永光,张猛,等.近十年国家自然科学基金对眼科学基础研究的资助分析及启示[J].中华实验眼科杂志,2020,38(10):864-870.
[5] Saletu M,Nosiska D,Kapfhammer G,等.阻塞性睡眠呼吸暂停(OSA)患者脑血管疾病的组织与血清替代标记物:轻度OSA与早期动脉粥样硬化的关系[J].世界核心医学期刊文摘:神经病学分册,2006(12):59-60.
[6] 冯葶,郭子宏.阻塞性睡眠呼吸暂停低通气综合征导致心血管疾病相关机制[J].中国老年保健医学,2021,19(1):101-105.
[7] 缪月红.基于IVOCT的冠状动脉粥样硬化斑块识别算法研究[D].南京:东南大学,2017.
[8] 张翀,李锋坦.高分辨率磁共振血管成像对颅内动脉粥样硬化斑块诊断作用的研究进展[J].天津医科大学学报,2021,27(2):204-207.
[9] 王婉洁.动脉血管和粥样硬化斑块的力学性能研究[D].南京:东南大学,2016.
[10] 龚婷,曹娟,彭清,等.巨噬细胞在动脉粥样斑块不同时期的作用[J].生命的化学,2020,40(8):1365-1370.
[11] Jian X,Liu Y,Zhao Z,et al. The role of traditional Chinese medicine in the treatment of atherosclerosis through the regulation of macrophage activity [J]. Biomed Pharmacother,2019,118:109375.
[12] Koelwyn GJ,Corr EM,Erbay E,et al. Regulation of macr-ophage immunometabolism in atherosclerosis [J]. Nat Immunol,2018,19:526-537.
[13] 王玉娜,苟德明.去乙酰化酶SIRT1在血管衰老中的作用机制研究进展[J].老年医学与保健,2020,26(6):901-904.
[14] Dai H,Sinclair DA,Ellis JL,et al. Sirtuin activators and inhibitors:Promises,achievements,and challenges [J]. Pharmacol Ther,2018,188:140-154.
[15] Morigi M,Perico L,Benigni A. Sirtuins in Renal Health and Disease [J]. J Am Soc Nephrol,2018,29(7):1799-1809.
[16] Khan RS,Fonseca-Kelly Z,Callinan C,et al. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells [J]. Front Cell Neurosci,2012,6:63.
[17] Bruckbauer A,Banerjee J,Cao Q,et al. Leucine-nicotinic acid synergy stimulates AMPK/Sirt1 signaling and regulates lipid metabolism and lifespan in Caenorhabditis elegans,and hyperlipidemia and atherosclerosis in mice [J]. Am J Cardiovasc Dis,2017,7(2):33-47.
[18] 瞿凯,邱菊辉,王贵学.血管内皮细胞屏障功能的血流动力学调控及其与动脉粥样硬化的关系[J].中国动脉硬化杂志,2020,28(1):1-6.
[19] Li B,He J,Lv H,et al. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow [J]. J Clin Invest,2019,129(3):1167-1179.
[20] Hsu PL,Chen JS,Wang CY,et al. Shear-induced CCN1 promotes atheroprone endothelial phenotypes and ather-osclerosis [J]. Circulation,2019,25(139):2877-2891.
[21] 王丹,谭真真,付斯麒,等.环状RNA在动脉粥样硬化中的研究进展[J].中国动脉硬化杂志,2021,29(1):1-9.
[22] Li CY,Ma L,Yu B. Circular RNA hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis [J]. Biomed Pharmacother,2017,95:1514-1519.
[23] Zhang S,Song G,Yuan J,et al. Circular RNA circ_0003204 inhibits proliferation,migration and tube formation of endothelial cell in atherosclerosis via miR370-3p/TGFβR2/phosph-SMAD3 axis [J]. J Biomed Sci,2020, 27(1):11.
[24] Isola AL,Chen S. Exosomes:the messengers of health and disease [J]. Curr Neuropharmacol,2017,15(1):157-165.
[25] Mohr AM,Mott JL. Overview of microRNA biology [J]. Semin Liver Dis,2015,35(1):3-11. |
|
|
|